Novartis Investigative Site

Tuscon, Arizona 85724

0 studies enrolling now · 2 studies all time

What they study most

Chronic Lymphocytic Leukemia (CLL), Leukaemia, Lymphocytic, Chronic, Rheumatoid Arthritis

Studies at this site

• Ofatumumab Plus Bendamustine in Frontline and Relapsed Chronic Lymphocytic Leukaemia (CLL) — Completed
• A Biomarker Study of Secukinumab in Rheumatoid Arthritis (RA) Patients — Completed